| Indicators | Browse All

XBiotech Inc. (XBIT)

Healthcare | Biotechnology | Austin, United States | NasdaqGS
2.33 USD +0.04 (1.747%) ⇧ (July 13, 2026, 4 p.m. EDT)
Short-term:★★☆☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | July 11, 2026, 2:50 a.m. EDT

XBiotech presents a classic value trap with deteriorating fundamentals and no catalyst to reverse the trend. The business is bleeding cash, reporting negative free cash flow and negative returns on both assets and equity. While the stock trades at a low price-to-book ratio, this discount reflects the reality that the company cannot generate sustainable earnings; the forward P/E relies on a tiny estimated EPS that may never materialize given the operational losses. The price history confirms this structural decline, with the stock down nearly 85% over the last nine years and just one positive annual return in that span. The recent drop of over 57% in the latest year suggests the market is aggressively repricing the asset based on its inability to turn profitable. There is no dividend to provide income, and the options market shows zero speculative interest, leaving investors with a high-risk, low-liquidity exposure to a failing biotech venture.
Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL_74 ✓0.022860
AutoTheta0.027955
AutoETS0.029507
MSTL0.055282
AutoARIMA0.057420
MSTL_74_1150.077533
MSTL_1150.110804

Forecast horizon: 60 days | Selected: MSTL_74

Forecast Reliability
Score 38%
H-stat 3.01
Ljung-Box p 0.000
Jarque-Bera p 0.082
Excess Kurtosis 0.83
Attribute Value
Sector Healthcare
Ex Dividend Date 2021-07-14
Last Dividend Date 2021-07-14
Market Cap 71,036,416
Forward P/E 17.92
Beta 0.84
Website https://www.xbiotech.com

As of July 11, 2026, 2:50 a.m. EDT: Options activity is sparse and lacks directional conviction. Call volume is negligible across all expirations, indicating no speculative demand for upside. Put activity is similarly low, concentrated only at the ATM strike, suggesting minimal hedging or bearish positioning. Implied volatility is extremely low, reflecting a lack of interest and uncertainty rather than a specific trade setup.

Dividend Data

Dividend History
Date Dividend Yield %
2021-07-15 2.5 15.087508
Additional Data
exDividendDate 2021-07-15
trailingAnnualDividendRate 0.0
trailingAnnualDividendYield 0.0
lastDividendValue 2.5
lastDividendDate 2021-07-15
dividendDate 2021-07-23

Info Dump

Attribute Value
52 Week Change -0.15272725
Address1 5,217 Winnebago Lane
All Time High 32.5
All Time Low 2.09
Ask 2.95
Ask Size 2
Average Daily Volume10 Day 39,120
Average Daily Volume3 Month 30,116
Average Volume 30,116
Average Volume10Days 39,120
Beta 0.844
Bid 1.65
Bid Size 2
Book Value 4.429
City Austin
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 2.33
Current Ratio 39.029
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 2.34
Day Low 2.28
Display Name XBiotech
Dividend Date 1,626,998,400
Earnings Timestamp End 1,755,259,200
Earnings Timestamp Start 1,754,909,940
Ebitda -46,833,000
Ebitda Margins 0.0
Enterprise To Ebitda 0.949
Enterprise Value -44,422,588
Eps Forward 0.13
Eps Trailing Twelve Months -1.31
Esg Populated 0
Ex Dividend Date 1,626,307,200
Exchange NMS
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fax 512 386 5505
Fifty Day Average 2.3984
Fifty Day Average Change -0.068400145
Fifty Day Average Change Percent -0.028519072
Fifty Two Week Change Percent -15.272724
Fifty Two Week High 3.61
Fifty Two Week High Change -1.28
Fifty Two Week High Change Percent -0.35457063
Fifty Two Week Low 2.09
Fifty Two Week Low Change 0.24000001
Fifty Two Week Low Change Percent 0.11483254
Fifty Two Week Range 2.09 - 3.61
Financial Currency USD
First Trade Date Milliseconds 1,429,104,600,000
Float Shares 22,837,750
Forward Eps 0.13
Forward P E 17.923077
Free Cashflow -30,622,624
Full Exchange Name NasdaqGS
Full Time Employees 87
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Held Percent Insiders 0.24327
Held Percent Institutions 0.06814
Implied Shares Outstanding 30,487,731
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Is Earnings Date Estimate 1
Language en-US
Last Dividend Date 1,626,307,200
Last Dividend Value 2.5
Last Fiscal Year End 1,767,139,200
Long Business Summary XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Long Name XBiotech Inc.
Market us_market
Market Cap 71,036,416
Market State PRE
Max Age 86,400
Message Board Id finmb_216818432
Most Recent Quarter 1,774,915,200
Net Income To Common -40,161,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 70,731,535
Open 2.28
Operating Cashflow -42,169,000
Operating Margins 0.0
Payout Ratio 0.0
Phone 512 386 2900
Pre Market Change 0.0
Pre Market Change Percent 0.0
Pre Market Price 2.33
Pre Market Time 1,784,031,888
Previous Close 2.29
Price Hint 4
Price To Book 0.5260781
Profit Margins 0.0
Quick Ratio 38.6
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.04
Regular Market Change Percent 1.74672
Regular Market Day High 2.34
Regular Market Day Low 2.28
Regular Market Day Range 2.28 - 2.34
Regular Market Open 2.28
Regular Market Previous Close 2.29
Regular Market Price 2.33
Regular Market Time 1,783,972,800
Regular Market Volume 78,681
Return On Assets -0.1881
Return On Equity -0.25933
Sand P52 Week Change 0.20365608
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 30,487,731
Shares Percent Shares Out 0.009
Shares Short 275,570
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 181,275
Short Name XBiotech Inc.
Short Percent Of Float 0.0106
Short Ratio 8.41
Source Interval 15
State TX
Symbol XBIT
Total Cash 115,459,000
Total Cash Per Share 3.787
Total Debt 0
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.31
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 2.4374
Two Hundred Day Average Change -0.10740018
Two Hundred Day Average Change Percent -0.04406342
Type Disp Equity
Volume 78,681
Website https://www.xbiotech.com
Zip 78,744